NCT05275699View on ClinicalTrials.gov

Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CT

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Keloid
Interventions
DRUG

68Ga-FAPI

Intravenous injection of one dosage of 18.5-22.2MBq (0.5-0.6 mCi)/Kg 68Ga-FAPI. Tracer doses of 68Ga-FAPI will be used to image lesions of keloid by PET/CT.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER